Sensei Biotherapeutics Inc
(HAM:407)
€
0.554
0.012 (2.21%)
Market Cap: 15.15 Mil
Enterprise Value: -33.83 Mil
PE Ratio: 0
PB Ratio: 0.28
GF Score: 36/100 - Sensei Biotherapeutics Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Sensei Biotherapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Sensei Biotherapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Sensei Biotherapeutics Inc at Citi Virtual Oncology Leadership Summit TranscriptFeb 23, 2023
- Sensei Biotherapeutics Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Sensei Biotherapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Sensei Biotherapeutics Inc Virtual VISTA Science Symposium TranscriptNov 16, 2021
- Sensei Biotherapeutics Inc to Discuss Prioritization of SNS-401-NG and SNS-VISTA Call TranscriptJun 28, 2021
Sensei Biotherapeutics Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022 / 07:25AM GMT
Release Date Price:
€1.35
(+0.07%)
Amalia Veerabahu
(Trades, Portfolio) LLC - Analyst
Good morning, everyone. And welcome to the Jefferies Healthcare Conference. I'm Amalia from Jefferies Investment Banking. And I'm delighted to introduce our next speaker, John Celebi, CEO of Sensei Biotherapeutics. Thank you.
John Celebi
Sensei Biotherapeutics, Inc. - President & CEO
Thank you, Amalia. And thank you to Jefferies for the invitation to the conference. Very excited to be here and tell you about our company.
As you can probably tell from our cover slide, we're an immuno-oncology company. It's a special mission for all of us. And I'm sure you all as I have been touched by cancer in some ways. In fact, just this morning, I got a text message from one of my oldest and dearest friends.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)